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 Abstract 
 
Objectives To examine which interventions health care professionals use to support 
patients with taking medicines and their perceptions about the effectiveness of those 
actions. 
Design Cross-sectional multinational study 
Setting Online survey in Austria, Belgium, England, France, Germany, Hungary, The 
Netherlands, Poland, Portugal, and Switzerland. 
Participants 3196 comprising doctors (855), nurses (1047) and pharmacists (1294) 
currently registered and practising in primary care and community settings. 
Main outcome measures  
Primary outcome: 
Responses to the question „I ask patients if they have missed any doses of their 
medication‟ for each profession and in each country.  
Secondary outcome: 
Responses to 50 items concerning healthcare professional behaviour to support 
patients with medication-taking for each profession and in each country. 
Results Approximately half of the healthcare professionals in the survey ask patients 
with long term conditions whether they have missed any doses of their medication on 
a regular basis. Pharmacists persistently report that they intervene less than the other 
two professions to support patients with medicines. No country effects were found for 
the primary outcome.  
Conclusions Healthcare professionals in Europe are limited in the extent to which 
they intervene to assist patients with long term conditions with medication adherence. 
This represents a missed opportunity to support people with prescribed treatment. 
These conclusions are based on the largest international survey to date of health care 
professionals‟ management of medication adherence. 
 
 
 
 
 
 
 
 Strengths and limitations of the study 
 
 This study is novel with a large, multi-national European sample of 3 health 
care professions (doctors, nurses and pharmacists), and is the largest survey 
to date of the behaviours undertaken in routine clinical practice in primary care 
to support patients with medicines use.  
 We provide evidence that there is scope for patients to be better supported 
with medicines use and the potential value of education and training for 
healthcare professionals to achieve this. 
 There is a risk of self-selection bias and risks inherent in the self-reporting of 
behaviour.  
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Introduction 
 
The majority of research on medication adherence has focussed on understanding 
and changing the patient, particularly their beliefs about medicines,1,2 rather than 
understanding and changing the context in which care and treatment is provided. 
Systematic reviews show that interventions designed to improve adherence for 
chronic health problems, such as patient education, psychological therapy, simplified 
dosing and family intervention, tend to be complex in nature and low in effectiveness.3 
 
Some research has examined the role of healthcare professionals in patients‟ 
adherence, although this has focused predominantly on physicians‟ communication 
and characteristics.4,5 Despite evidence from this research suggesting that healthcare 
professionals can significantly affect patients‟ adherence to medication, the beliefs, 
perceptions and practices of healthcare professionals have received relatively little 
attention. The effectiveness of adherence-enhancing interventions needs to be 
examined in a broader context, which encompasses the role of healthcare 
professionals. Healthcare professionals have an important role to play in providing 
support to patients in order to ensure that if patients agree to take medicines, they are 
used in a safe, effective, and cost-effective way. However, evidence suggests that 
healthcare professionals may not be fulfilling this role, in part as they tend to 
underestimate the incidence of non-adherence in their patients.6 Few physicians 
receive formal training in patient adherence, though the assessment of patient 
adherence and the use of adherence-enhancing interventions is significantly greater 
among those who do receive formal training.7 Improving the skills of healthcare 
professionals in properly assessing the risk of non-adherence in patients and 
delivering interventions aimed at reducing non-adherence, may therefore lead to 
more effective support for patients taking prescribed medicines.  
 
In order to gain a more complete understanding of the range of potentially adherence-
enhancing interventions delivered by healthcare professionals in routine daily practice 
and their perceived effectiveness, we conducted a survey of doctors‟, nurses‟ and 
pharmacists‟ adherence management across 10 European countries.  
 
 
 
 
Methods 
 
Design 
The paper focuses on the self-reported behaviours of primary care healthcare 
professionals in 10 European countries to support patients with taking prescribed 
medicines for long-term conditions, using a cross-sectional online survey. The 
protocol for this study has been published elsewhere.8  
 
Setting and participants 
Participants were healthcare professionals who were currently registered to practice 
and employed as medical doctors, nurses or pharmacists, working with adults in 
primary or community care in one of ten European countries: Austria, Belgium, 
England, France, Germany, Hungary, The Netherlands, Poland, Portugal, and 
Switzerland. 
 
Sample size was based on the estimation of the proportion of those participants who 
answer “never” to the primary outcome: „I ask patients if they have missed any doses 
of their medication‟ in each country. Following Cochran,9 a sample size of 384 health 
care professionals in each country (128 people for each professional group) was 
required to enable estimation with 95% confidence.  
 
Procedure 
A mixed-method approach was used to recruit participants in each country, adapted 
as necessary dependent upon the availability and accessibility of national registers of 
healthcare professionals. Recruitment was via professional bodies and associations 
when registers were not available.  
 
The online questionnaire was administered using SurveyMonkey.com 
(http://www.SurveyMonkey.com). No personal information (such as names, 
addresses and professional licence numbers) were collected from participants and no 
IP addresses were stored or downloaded. Ethics approval was provided by the NRES 
Committee North West Liverpool East (REC Reference 11/NW/0156) for England and 
used as the basis for ethics and research governance in the other European 
countries, adapted as necessary to meet national ethical requirements.  
 
 
Measures 
It was not possible to identify any validated scales of healthcare professional 
behaviour in this domain, but two unvalidated, published questionnaires have been 
used to measure adherence intervention behaviours and their perceived effectiveness 
among hospital-based doctors4 and cardiovascular and transplantation nurses.10 Our 
questionnaire was informed by these previous studies, recommendations for clinical 
practice from published adherence guidelines,1,10-12 and was discussed, reviewed, and 
piloted by the research team. The questionnaire is available from the corresponding 
author. 
 
Fifty questions concerning adherence-enhancing interventions were presented in five 
sub-sections: assessment of adherence and its risk factors (example item, „I use 
electronic monitoring devices to assess patients‟ level of adherence‟); providing 
information for carers and patients (e.g., „I check that patients understand the 
information that I have given them‟); talking with patients about their medications 
(e.g., „I ask patients what level of involvement they would like in making decisions 
about their treatment‟); practical strategies to make medication taking easier (e.g., „I 
help patients to tailor their medication regimen to their own lifestyle‟); and involving 
others and services to support adherence (e.g., „I refer patients to peer mentor 
programmes to support medication adherence‟). Following Berben et al.11 
respondents were asked how often they used each intervention (from „never‟ to „all 
the time‟ with the response category „not applicable‟ available to participants who did 
not use the intervention mentioned) and how effective they think that intervention is 
(„not at all‟ „somewhat‟, „extremely‟, with the option of responding „don‟t know‟). 
 
The survey was translated into the appropriate languages using accredited translators 
who were native speakers of the target languages and fluent in English. Translations 
were checked for compatibility with the original version in a process of back 
translation, performed by persons who were native English speakers and fluent in 
each target language. For each language, a third individual acted as a reviewer and 
highlighted any discrepancies between the forward and back translations, which were 
resolved by discussion with the translators. Translations were coordinated by one 
project partner to ensure consistency. Piloting in each country enabled identification 
of any semantic inconsistencies. 
 
Primary and secondary outcomes 
The primary outcome was responses to the question „I ask patients if they have 
missed any doses of their medication‟ for each profession and in each country.  
Secondary outcomes were responses to the 50 items concerning healthcare 
professional behaviour to support patients with medication-taking for each profession 
and in each country. 
 
Statistical analysis 
Quantitative analyses for the primary outcome were performed using MLwiN 
(http://www.cmm.bristol.ac.uk/MLwiN/) for both binary and ordered categories. 
Responses to the primary outcome were categorised to form a binary variable coded 
as 1 if the intervention had never been used and 0 for all other response options. 
Participants who indicated that the item was not applicable to their particular role 
were excluded from the analysis. Post hoc we found that the frequency of the primary 
outcome (never asking patients if they had missed any doses of their medication) 
produced a relatively small number of responses; consequently a further analysis was 
carried out using the binary outcome where patients were asked frequently or all the 
time about missed doses. 
 
Analysis of primary outcome 
We evaluated the effect on the primary outcome of groups of predictor variables. The 
group of demographics variables comprised gender and age of respondents, while 
professional practice encompassed number of years registered as a qualified 
healthcare professional, the average amount of time spent talking with patients about 
their use of medications, any pre-registration or post-registration training in 
medication adherence management and support, and the use of practitioner 
guidelines to assist with the management of patients‟ adherence. Multiple logistic 
regression was used, taking into account the hierarchical nature of the data, and the 
results are presented as Odds Ratios (ORs) and their 95% confidence intervals. 
Where there were ordinal responses the lowest was taken as the comparator value 
and ORs are presented for the binary responses for categorical variables, for instance 
the use of practitioner guidelines to assist with the management of patient adherence. 
Where there are variables measured over a more extensive range, such as age, then 
ORs represent the change per unit (per year for age). Where there appeared to be a 
trend in the predictors this was tested. Logistic regressions were applied with random 
intercepts which were allowed to vary at both the country and profession level and 
fixed effects for all variables within the three groups. A preliminary analysis where the 
intercept was allowed to vary at the country level and with a profession fixed effect is 
also given. In practice in most cases the country effects were not significant and 
models were refitted with only profession random effects.  
 
Structure of analysis 
Two sets of between-subjects analysis of variance (ANOVA) were conducted on the 
data on healthcare professionals‟ use of adherence-enhancing interventions. First, a 
series of ANOVAs are reported for the main effects of profession and nation on 
healthcare professionals‟ total ratings for each of the five categories of adherence-
enhancing interventions and perceived barriers to implementing interventions for 
adherence. Data for all professions and all participating nations were included in 
these analyses. To enable testing for potential interactions between profession and 
nation for each of the outcome variables, a second series of ANOVAs is reported. As 
data were not collected from nurses in France and Germany, the data from these 
nations were excluded in this second series of analyses. The sample sizes for both 
sets of analysis were considered large enough so that normality based tests were 
appropriate, however inferences were checked using the non-parametric Kruskall-
Wallis test. 
 
Analysis of variance: Main effects 
All analyses were carried out using NCSS 2007 (version 07.1.19, J. Hintze (2009) 
Kaysville Utah USA). Initially, a series of 3 x 10 between-subjects ANOVAs using the 
General Linear Model (GLM) procedures were conducted to examine the main effects 
of profession and nation on total scores for healthcare professionals‟ use of 
adherence-enhancing interventions for each category of intervention. Corrections for 
multiple testing were carried out within each variable.  
 
Analysis of variance: Interaction effects 
As data were not collected from nurses in France or Germany, a further series of 
ANOVAs was necessary to explore the effects of interactions between profession and 
nation on total ratings for healthcare professionals‟ use of adherence-enhancing 
interventions. 
 
Results 
A total of 4967 healthcare professionals started the survey. 3196 reported their 
profession and were included in the analysis. Demographic information for the sample 
is presented in Table 1. Means and standard deviations for specific adherence- 
enhancing interventions by profession and by nation can be found in supplementary 
tables 1 – 4.  
 
Primary outcome 
For both versions of the primary outcome, the ORs and their confidence intervals 
suggest that pharmacists are approximately 2.8 times more likely to have a never 
response to the question „I ask patients if they have missed any doses of their 
medication‟ than doctors, and the doctors and nurses were not significantly different 
from each other. Pharmacists are also approximately 4.6 times less likely to ask 
patients frequently or all the time if they have missed any doses of their medication. 
The results for both outcomes are presented in Tables 2 and 3. 
 
The country random effect was found to be non-significant.  Both age and gender 
were found to have non-significant effects with ORs near 1 and 95% confidence 
intervals containing 1. Length of time registered as a qualified healthcare professional 
appears to have a positive effect on both outcomes. This is more marked for the 
never asked outcome; however there is no discernible trend over the categories. For 
length of time spent talking with patients about their use of medications, there is a 
significant trend downwards (OR = 0.524 per unit change, 95% confidence interval, 
0.36- 0.727) and upwards (OR = 1.42 per unit change, 95% confidence interval, 1.27- 
1.57). Training, which was a binary variable reflecting any pre-registration and/or 
post-registration training in medication adherence management and support, has a 
nearly significant effect for the never category, where those who reported training 
were approximately 60% less likely to never ask patients about missed doses. For the 
frequently/always outcome, training predicts an approximately 42% increase in this 
outcome. The use of practitioner guidelines to assist with the management of patient 
adherence to medication does not reach significance but point estimates of the ORs 
indicate similar positive effects for both outcomes. 
 
Internal reliability of measures 
Cronbach‟s alphas indicated that the items assessing „providing information for 
patients/carers‟ (α = 0.80), „talking with patients about their medications‟ (α = 0.87), 
„practical strategies to make medication taking easier‟ (α = 0.83), and „involving 
others, and other services, to support adherence‟ (α = 0.72) showed good internal 
reliability. The internal reliability of the measure for „assessment of adherence and its 
risk factors‟ fell marginally below the accepted level of 0.70 (α = 0.69). Results 
derived from the total ratings for this section should therefore be interpreted with 
caution.  
 
Some categories of interventions were found to have a high correlation with each 
other, using Pearson‟s r with a cut-off level of 0.5. Higher scores for frequency of use 
of assessment interventions were found to correlate with higher scores for the use of 
interventions focussed on talking with patients about their medications (r = 0.53). High 
scores for the use of interventions focussed on talking with patients about their 
medications were also correlated with higher reported use of practical strategies to 
make medication taking easier (r = 0.58). 
 
Analysis of variance: Main effects 
For the assessment of adherence and its correlates, a significant main effect was 
obtained for profession, F (2, 1678) = 129.48, p < 0.001. A Bonferroni multiple 
comparison test at the 5% level of significance showed that all three professional 
groups were significantly different from each other. Nurses reported significantly 
greater use of these interventions than doctors and pharmacists. Doctors also 
reported significantly greater use of these interventions than pharmacists, p < 0.05. 
There was also a significant main effect of nation on reported use of interventions for 
the assessment of adherence and its risk factors, F (9, 1678) = 4.99, p < 0.001. 
England, Portugal and the Netherlands showed greater use of these interventions 
and French healthcare professionals showed the lowest use of assessment 
interventions. 
 
For interventions focused on providing information for patients or carers, there was a 
significant main effect of profession on healthcare professionals‟ reported use, F (2, 
1990) = 62.36, p < 0.001. A Bonferroni multiple comparison test indicated that doctors 
reported significantly more frequent use of these interventions than nurses or 
pharmacists, and nurses used these interventions significantly more often than 
pharmacists, p < 0.05. A significant main effect of nation was also determined, F (9, 
1990) = 14.06, p < 0.001. Again, healthcare professionals in England, the 
Netherlands and Portugal reported more frequent use of these interventions. Austrian 
healthcare professionals reported the lowest use of this category of intervention.  
 
The ANOVA conducted on the total use of interventions regarding talking with 
patients about their medications revealed a significant main effect of profession, F (2, 
547) = 40.83, p < 0.001. A Bonferroni multiple comparison test showed that nurses 
reported significantly more use of these interventions than doctors and pharmacists, 
and doctors reported significantly greater use than pharmacists, p < 0.05. There was 
also a significant main effect of nation, F (5, 547) = 4.41, p < 0.001. More use of these 
interventions was reported by healthcare professionals in Portugal and the 
Netherlands, and the least use was reported by Belgium.  
 
For healthcare professionals‟ reported use of practical strategies to make medication 
taking easier, a significant main effect of profession was determined, F (2, 1249) = 
86.34, p < 0.001. A Bonferroni multiple comparison test showed that doctors reported 
significantly greater use of these interventions than nurses and pharmacists, and 
nurses reported significantly more use than pharmacists, p < 0.05. A significant main 
effect of nation also emerged, F (8, 1249) = 7.19, p < 0.001. Use of these 
interventions was highest in England, the Netherlands and Portugal and lowest in 
Austria and Switzerland.   
 
For the final category of interventions, focused on involving others, and other 
services, to support adherence, a significant main effect of profession was found, F 
(2, 1408) = 63.85, p < 0.001. A Bonferroni multiple comparison test revealed that 
nurses reported significantly greater use of these interventions than doctors and 
pharmacists, p < 0.05. Further, the mean total reported use of these interventions by 
doctors was significantly higher than the mean total use by pharmacists, p < .05. A 
significant main effect of nation was also observed for this outcome, F (9, 1408) = 
26.55, p < 0.001. Healthcare professionals in Poland reported the highest use of 
these interventions, and Austria, Germany and Switzerland the least.  
 
Analysis of variance: Interaction effects 
For the category of interventions pertaining to the assessment of adherence and its 
risk factors, a significant main effect of profession was determined, F (2, 1445) = 8.98, 
p < 0.01. There was, however, no significant main effect of nation, F (7, 1445) = .62, p 
> 0.05. A significant interaction between profession and nation emerged, F (14, 1445) 
= 7.73, p < 0.001. Pharmacists in England, the Netherlands and Portugal reported 
more use of these interventions than pharmacists from other countries. Nurses in 
Austria and Switzerland reported less use of these interventions than nurses in other 
countries. 
 
There were no significant main effects of profession, F (2, 1689) = 1.35, p > 0.05, or 
nation, F (7, 1689) = 1.30, p > 0.05, on healthcare professionals‟ reported use of 
interventions centred on the provision of information for patients and carers. However, 
a significant profession x nation interaction was found, F (14, 1689) = 8.83, p < 0.001. 
Nurses in England reported much higher, and nurses in Austria much lower, use of 
these interventions than nurses in other nations. Pharmacists in the Netherlands and 
Portugal reported more frequent use of these interventions, and pharmacists in 
Poland and Switzerland less frequent use of these interventions. 
 
For the use of interventions focused on talking with patients about their medications, 
a significant main effect of profession was determined, F (2, 471) = 7.80, p < 0.05. 
There was no significant main effect of nation, F (4, 471) = 2.03, p > 0.05. However, a 
significant profession x nation interaction effect was found, F (8, 471) = 2.52, p < 
0.05. Nurses in the Netherlands reported higher use of interventions in this category 
than nurses in other countries. Pharmacists in Belgium and Switzerland reported 
lower use of interventions in this category. 
 
A similar pattern of findings was determined for healthcare professionals‟ use of 
practical strategies to make medication taking easier. A significant main effect of 
profession was found, F (2, 1064) = 10.50, p < 0.01, but there was no significant main 
effect of nation, F (6, 1064) = 1.42, p > 0.05. A significant interaction effect was found, 
F (14, 1064) = 4.18, p < .001. Doctors in England, the Netherlands and Switzerland 
reported lower use of these interventions than doctors in other nations. Nurses and 
pharmacists in England and the Netherlands had higher use of interventions in this 
category than nurses elsewhere. 
 
For the final category of interventions, focused on involving others and other services 
to support adherence, significant main effects were found for profession, F (2, 1201) 
= 8.19, p < 0.01, and for nation, F (7, 1201) = 6.95, p < 0.01. Nurses reported 
significantly greater use of these interventions than doctors and pharmacists, p < 
0.05  Healthcare professionals in Portugal and Poland reported more frequent use of 
interventions than healthcare professionals in other nations. A significant profession x nation 
interaction effect was also shown, F (14, 1201) = 3.44, p < 0.001. Pharmacists in Poland 
reported much lower use of these interventions than Polish doctors and nurses that 
completed the survey.   
 
 
  
Discussion 
 
Main findings  
Healthcare professionals in Europe are limited in the extent to which they intervene to 
assist patients with long term conditions with medication adherence. Within 
intervention categories, mean total scores are around or below the mid-point for 
„assessment of adherence‟, „practical strategies to make medication taking easier‟, 
and „involving others to support adherence‟. The categories „providing information for 
patients/carers‟ and „talking with patients about their medications‟ (of which giving 
patients the opportunity to ask questions is highly rated) both score slightly above the 
mid-point of the total scale, suggesting these categories of intervention are practised 
somewhat more frequently.  
  
The analysis of the primary outcome, and of the „assessment of adherence‟ category 
as a whole, generates concern about the extent to which healthcare professionals 
seek to identify medication non-adherence in routine clinical practice. Participants in 
the survey were asked to answer each question only if the specific item was relevant 
to their role. Thus participants for whom the item was relevant to their role, and so 
answered the question, could potentially have asked all patients about missed doses 
of prescribed medication. In fact, about half of the healthcare professionals in the 
survey ask patients with long term conditions whether they have missed any doses of 
their medication on a regular basis, a question identified as a key method for 
healthcare professionals to assess adherence and so support patients with 
medicines.12 However, the finding that healthcare professionals who report that they 
have had some element of training in medication adherence are more likely to ask 
this key question, indicates that healthcare professional behaviour may be amenable 
to change in this regard.  
 
Consistent differences were found in the extent to which doctors, pharmacists and 
nurses report that they manage and support patients with medication adherence. For 
the primary outcome, and all five categories of adherence intervention, pharmacists 
persistently report that they intervene less than the other two professions to support 
patients with medicines. In three instances of five, nurses reported more intervention 
than doctors to assist patients with prescribed medicines. 
 The differences between professions in the extent to which they report that their day 
to day practice includes supporting patients with long term conditions with medicines 
use is cause for concern. Within the primary care team, pharmacists have particular 
expertise and training in pharmaceuticals, yet this does not appear to translate into a 
lead role in supporting patients with medicines use within routine practice. It is 
possible that the physical environment and role of many pharmacists in community 
and primary care settings may hinder their ability to assist patients to the same extent 
as nurses and doctors. However, in this survey pharmacists report no less time to 
spend talking with patients about their use of medications than doctors, though both 
groups report that they typically have less time to spend with individual patients than 
nurses. It is also unlikely that access to training inhibited pharmacists from intervening 
to support patients with medication adherence: pharmacists in this study reported 
receiving more adherence training than either nurses or doctors. Future research 
might usefully consider whether aspects of service provision, type and nature of 
training or healthcare culture contribute to these differences in clinical behaviour.  
 
 
No country effects were found for the primary outcome examining responses to the 
question specifically concerning whether healthcare professionals ask patients if they 
have missed any doses of their medication. Differences between countries were 
found in the extent to which healthcare professionals in primary care settings 
intervene to support patients with medicines use. Healthcare professionals in 
England, the Netherlands and Portugal report more activity to support patients with 
medicines use for three of the five categories of intervention („assessment of 
adherence‟, „providing information for patients/carers‟ and „practical strategies to 
make medication taking easier‟) than healthcare professionals in the other countries. 
Healthcare professionals in the Netherlands and Portugal, but not England, also 
report more activity in the „talking with patients about medications‟ category. The 
pattern of findings is different for the „involving others and other services to support 
adherence‟ category, for which Polish healthcare professionals report more activity 
than healthcare professionals in other countries. Interaction effects between 
profession and countries are reported above for completeness but should be 
interpreted with caution in the absence of a main effect of country in the majority of 
these analyses.  
 
The relatively small sample of healthcare professionals in Portugal cautions against 
over-interpretation of findings for this nation. Results from England, the Netherlands 
and Poland however, are supported by much larger samples.  
 
A clear theme regarding the use of adherence-enhancing interventions by healthcare 
professionals is the low reported use of technology and other resources to support 
patients with medicines use in routine practice. Resource-intensive approaches are 
utilised less than resource-light approaches. Thus, blood or urine screens and 
electronic monitoring to assess medication adherence, DVDs, video or computer 
resources for information provision, and reminder systems such as text messaging, 
mobile alarms, reminder charts and diaries are used less to support medication 
adherence than non-technological, simple approaches, such as information sharing 
and talking with patients about their medicines use. Unfortunately from this survey, 
we are unable to determine whether this is due to the lack of availability of such 
resources or a preference by healthcare professionals for less technologically-driven 
approaches. However, we do know that healthcare professionals who report use of 
these resource-intensive interventions, and thus respond to the questions about 
perceived effectiveness of the intervention items, are in general more likely to report 
that they „don‟t know‟ how effective the interventions are than participants responding 
to other items.  
 
Healthcare professionals in the study reported that, of the interventions they use, 
provision of information to patients and talking with patients about their medicines 
use, are more effective than other ways of intervening, in their view. However, the 
sample does not strongly endorse the effectiveness of many of the interventions they 
use; just 10 of the 50 interventions have a modal response of „extremely‟ effective.  It 
is possible then that healthcare professionals struggle to get feedback on the utility 
and effectiveness of their own actions to support patients with medication adherence. 
If so, healthcare professionals may find it difficult to reflect upon, learn from and adapt 
their own practice to support medicines use. 
 
Strengths and limitations 
In some countries, and for some professions, participant recruitment did not reach the 
target sample size. Recruitment of general practitioners to the study was a particular 
problem for some countries. In England, for example, recruitments of pharmacists and 
nurses to the study was steady and straightforward. Professional bodies and 
regulators for GPs, however, were less able to assist with recruitment. Two countries, 
France and Germany, did not plan to collect data for nurses working in a primary care 
setting. Survey partners in those countries reported that the study topic was not so 
relevant to the role of nurses in those nations. For some analyses, the absence of a 
nurse sample for all countries meant that interaction effects could not be reported 
unless the whole dataset for these specific countries was excluded.  
 
The study focused on the behaviours of healthcare professionals working in a primary 
care setting. This study does not tell us about behaviours to support medication 
adherence by those working in secondary care health services, nor is it possible to 
determine the extent to which the results of the present study may be generalizable to 
other settings. The survey concerns self-report by healthcare professionals of the 
interventions they undertake to manage and support patients with medication 
adherence. We have no objective evidence to support these self-reports. Equally, we 
have no information about the patient experience of support with medicines taking by 
the professionals participating in the study. Furthermore, healthcare professionals 
completing this survey chose whether to participate or not. This self-selected sample 
may be more interested in medicines and medicines use than the healthcare 
professional population at large. If so, this study may overestimate the proportion of 
healthcare professionals who use adherence-enhancing interventions. 
 
To our knowledge, however, this study is the largest survey of European healthcare 
professionals‟ behaviour to support patients with medication adherence. Keeping in 
mind the caveats above, the results add to our understanding of how frequently 
healthcare professionals intervene to support patients with medicines use in everyday 
practice, and their perceptions of the efficacy of that intervention. The international 
nature of this study enables analysis of variability observed in healthcare 
professionals' beliefs and behaviours across 10 European nations.  This may provide 
a basis within each country for promoting routine and continuous efforts to educate 
and modify the behaviour of healthcare professionals in order to enable them to fulfil 
their roles in supporting patients with medicine taking. 
 
Implications for clinicians and policymakers  
Our study shows that there is plenty of scope for primary care healthcare 
professionals to increase the frequency with which they provide support to patients 
with long term conditions prescribed medication.  
 
This study provides evidence to support a strong case for educators to reflect on the 
nature and extent of the education and training provided to healthcare professionals 
for managing and supporting patients with medication adherence. Our educational 
framework, based in part on this survey,13 which includes a competency framework, 
learning outcomes and an assessment tool, may form a basis for education for pre-
registration training and for continuing professional development for healthcare 
professionals. 
 
We recommend that a quality standard for medication adherence support for people 
with long term conditions should be implemented in primary care settings in Europe 
based on the following quality statement: people prescribed medication(s) for long 
term conditions receive an assessment that identifies the extent of their non-
adherence to medication. The recommended quality measure is the proportion of 
patients prescribed medication who are asked whether they have missed any doses 
of their medication for a recent timeframe during their most recent consultation 
(numerator – the number of people with a long term condition prescribed medication 
who were asked whether they have missed any doses of their medication during their 
most recent consultation; denominator - the number of all patients with a long term 
condition prescribed medication). The aim of this quality standard is to make 
medication adherence assessment a regular and routine part of primary health care, 
and so provide a basis for healthcare professionals to support patients reporting non-
adherence with medicines use when necessary. 
 
Unanswered questions and future research 
Further study is needed to investigate ways in which healthcare professionals can 
receive feedback about the impact and effectiveness of specific adherence-enhancing 
interventions used in routine clinical practice, to support them in reflecting upon and 
improving their practice. Previous studies of clinical behaviour change for other 
aspects of clinical practice have used social cognitive theory to understand the 
determinants of healthcare professional behaviour and as the basis for the design of 
interventions to change the clinical practice of healthcare professionals.14, 15, 16 Future 
research might adopt the same approach in the development of interventions to 
improve the uptake of medication adherence guidelines by healthcare professionals. 
 
We have also identified a discrepancy between the nature of medicines adherence 
support provided in routine clinical practice and the nature of the often complex 
adherence-enhancing interventions reported in intervention studies.3 The 
implementation of trial-based interventions into routine clinical practice is likely 
therefore to need careful consideration. 
 
Conclusion 
Healthcare professionals in Europe are limited in the extent to which they intervene 
to assist patients with long term conditions with medication adherence. This 
represents a missed opportunity to support people with prescribed treatment.  
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Table 1. Demographic data  
Sample size  Total N = 3196; Austria = 698; Belgium = 289; England = 318; France = 133; Germany = 303;  Hungary = 322; Netherlands = 91; 
Poland = 571; Portugal = 53; Switzerland =418; Doctors = 855; Pharmacists = 1294; Nurses = 1047  
Age (mean and standard deviation) 44.77 (10.96) 
Gender Male = 1102; Female = 2069 
Years since qualifying (frequency 
distribution) 
Less than one 
year 
 
N = 86 
1-5 years 
 
 
N = 354 
6-10 years 
 
 
N = 374 
11-15 years 
 
 
N = 439 
Over 15 years 
 
N = 1935 
 
Type of healthcare setting (frequency 
distribution) 
Community 
hospital 
 
 
 
N = 385 
Family 
medication/g
eneral 
practice 
 
N = 820 
Specialist 
community 
service 
 
 
N = 104 
Care/ 
nursing 
home 
 
 
N = 155 
Community 
pharmacy/ 
dispensary 
 
 
N = 1175 
Community 
nursing 
team 
 
 
N = 154 
Polyclinic 
 
 
 
 
N = 45 
Other 
 
 
 
 
N = 308 
Type of healthcare organisation (frequency 
distribution) 
Privately 
funded 
 
 
N = 1127 
State funded 
 
 
N = 1050 
Insurance/ 
sick fund 
funded 
 
N = 531 
Mixed 
funded 
 
 
N = 44 
Other funding 
 
 
N = 302 
 
Length of time spent talking to patients 
about their use of medications (frequency 
distribution) 
No time at all 
 
 
N = 34 
Less than 
one minute 
 
N = 158 
1-5 minutes 
 
 
N = 1715 
6-10 minutes 
 
N = 801 
11-15 minutes 
 
N = 226 
More than 
15 minutes 
 
N = 199 
 
Pre-registration training in medication 
adherence management and support 
(frequency distribution) 
Yes 
 
N = 296 
No 
 
N = 1780  
 
Post-registration training in medication 
adherence management and support 
(frequency distribution) 
Yes 
 
N = 684  
No 
 
N = 1392  
 
Any training in medication adherence 
management and support (frequency 
distribution) 
Yes 
 
N = 803 
No 
 
N = 1268  
 
Use of practitioner guidelines to assist with 
management of patient adherence to 
medication (frequency distribution) 
Yes 
 
N = 468 
No 
 
N = 1586 
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Table 2. Summary of multiple logistic regression for never asking patients about missed doses as the dependent variable 
Variable  OR 95% CI 
Profession* Doctor 1.00  
 Pharmacist  2.80 1.71 – 4.58 
 Nurse 0.92 0.50 – 1.69  
Demographics**    
Gender Male 1.00  
 Female 0.91 0.59 – 1.43 
Age Per year 1.02 0.84 – 1.24 
Professional practice**    
Number of years registered as a qualified healthcare professional Less than 1 year 1.00  
 1-5 years 0.22 0.07 – 0.71 
 6-10 years 0.40 0.14 – 1.17 
 11-15 years 0.31 0.10 – 0.92 
 Over 15 years 0.22 0.08 – 0.60 
Time spent talking with patients about their use of medications No time at all 1.00  
 Less than one minute 0.63 0.13 – 3.19 
 1-5 minutes 0.18 0.04 – 0.84 
 6-10 minutes 0.05 0.01 – 0.27 
 11-15 minutes 0.08 0.01 – 0.57 
 More than 15 minutes 0.11 0.02 – 0.71 
Pre-registration and/or post-registration training in adherence 
management and support 
No 
Yes 
1.00 
0.59 
 
0.33 – 1.06 
 
Use of practitioner guidelines to assist with management of patient 
adherence to medication 
No 
Yes 
1.00 
0.82 
 
0.42 – 1.58 
* intercept allowed to vary by country; ** intercept allowed to vary by profession
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Table 3. Summary of multiple logistic regression for asking patients about missed doses frequently or all the time as the dependent 
variable 
Variable 
 
 OR 95% CI 
Profession* Doctor 1.00  
 Pharmacist  0.22 0.17 – 0.27 
 Nurse 1.12 0.90 – 1.41 
Demographics**    
Gender Male 1.00  
 Female 1.02 0.84 – 1.23 
Age Per year 1.01 1.00 – 1.01 
Professional practice**    
Number of years registered as a qualified healthcare professional Less than 1 year 1.00  
 1-5 years 2.19 1.09 – 4.38 
 6-10 years 2.32 1.16 – 4.63 
 11-15 years 1.90 0.96 – 3.77 
 Over 15 years 2.08 1.08 – 4.00 
Time spent talking with patients about their use of medications No time at all 1.00  
 Less than one minute 3.69 0.72 – 18.95 
 1-5 minutes 3.88 0.80 – 18.89 
 6-10 minutes 6.12 1.25 – 29.95 
 11-15 minutes 8.40 1.67 – 42.31 
 More than 15 minutes 9.10 1.80 – 46.01 
 
  
 27 
 
Pre-registration and/or post-registration training in adherence 
management and support 
No 
Yes 
1.00 
1.42 
 
1.16 – 1.74 
Use of practitioner guidelines to assist with management of patient 
adherence to medication 
No 
Yes 
1.00 
1.21 
 
0.96 – 1.52 
* intercept allowed to vary by country; ** intercept allowed to vary by profession 
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